BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10855258)

  • 81. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
    Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
    Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of technetium-99m hexakis-2-methoxyisobutyl isonitrile in the detection of neoplastic lung lesions.
    Santini M; Fiorello A; Mansi L; Rambaldi PF; Vicidomini G; Busiello L; Messina G; Nargi P
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):325-31. PubMed ID: 18996706
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
    Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
    Chen YK; Liu FY; Yen RF; Kao CH
    Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [A proposal for the rational use of the PET in oncology].
    Borrego Dorado I; Vázquez Albertino R
    Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Solitary pulmonary nodule and (18)F-FDG PET/CT. Part 2: accuracy, cost-effectiveness, and current recommendations.
    Mosmann MP; Borba MA; de Macedo FP; Liguori Ade A; Villarim Neto A; de Lima KC
    Radiol Bras; 2016; 49(2):104-11. PubMed ID: 27141133
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical PET in Oncology.
    Coleman RE
    Clin Positron Imaging; 1998 Dec; 1(1):15-30. PubMed ID: 14516605
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Changes over the years in radiopharmaceutical design.
    Eckelman WC; Kuwert T; Ciarmiello A; Riondato M; Mansi L
    Q J Nucl Med Mol Imaging; 2022 Sep; 66(3):261-271. PubMed ID: 31833739
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging.
    Greenspan BS
    Transl Lung Cancer Res; 2017 Dec; 6(6):617-620. PubMed ID: 29218264
    [TBL] [Abstract][Full Text] [Related]  

  • 93. One-day examination of triple nuclear medicine imaging and application in evaluating transarterial embolization.
    Du N; Jia G; Zhang W; Tong Q; Qu X; Liu R; Li D; Yan Z; Zuo C; Li X; Li R; Zhang W
    Heliyon; 2024 May; 10(9):e29597. PubMed ID: 38707399
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nuclear Medicine in the diagnosis of pathologies of the spine: role of hybrid imaging.
    Noriega-Álvarez E; Domínguez Gadea L; Sanz Viedma S; Del Prado Orduña Diez M; Minoves Font M; Peiró Valgañón V; García Jiménez R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(1):37-49. PubMed ID: 33041242
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Current Applications for Nuclear Medicine Imaging in Pulmonary Disease.
    Kusmirek JE; Magnusson JD; Perlman SB
    Curr Pulmonol Rep; 2020; 9(3):82-95. PubMed ID: 32837866
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Contributions of nuclear medicine in paediatric non-tumour musculoskeletal pathology.
    Noriega-Álvarez E; Orduña Diez MDP; Domínguez Gadea L; Sanz Viedma S; Loza SM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(3):188-201. PubMed ID: 33824088
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Molecular imaging of pulmonary diseases.
    Dimastromatteo J; Charles EJ; Laubach VE
    Respir Res; 2018 Jan; 19(1):17. PubMed ID: 29368614
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Multi-Energy Imaging in Nuclear Oncology.
    Wagner HN
    Clin Positron Imaging; 1998 Dec; 1(1):47-50. PubMed ID: 14516607
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.